Preclinical study index · Research use only

Glow: preclinical and in-vitro studies

9 published studies on the components of Glow, limited by rule to animal models and cell-based (in vitro) work indexed in PubMed, spanning 2020 to 2026 across 9 journals. Human trials, case reports and literature overviews are excluded. Titles appear as published; each links to its PubMed record and, where one is registered, its DOI. Glow is a blend, so the index lists studies per component: GHK-Cu (3), BPC-157 (3), TB-500 (3).

  • 9studies listed
  • 9with an animal model
  • 3with in-vitro work
  • 2020 to 2026publication years
  • 9journals

Evidence table

#YearStudyJournalModelRecord
1 2026 The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathwaysGHK-Cu · PMID 42084774 Biogerontology C. elegans model and in vitro PubMed · DOI
2 2020 Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathwaysGHK-Cu · PMID 31809714 Life sciences Mice model PubMed · DOI
3 2020 Hydrogels based on low-methoxyl amidated citrus pectin and flaxseed gum formulated with tripeptide glycyl-l-histidyl-l-lysine improve the healing of experimental cutting wounds in ratsGHK-Cu · PMID 33031852 International journal of biological macromolecules Rats model PubMed · DOI
4 2026 Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injuryBPC-157 · PMID 42204242 Scientific reports Rats model PubMed · DOI
5 2026 Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical studyBPC-157 · PMID 42542926 Joint diseases and related surgery Rats model PubMed · DOI
6 2024 Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpointBPC-157 · PMID 38583442 Journal of physiology and pharmacology : an official journal of the Polish Physiological Society Rats model PubMed · DOI
7 2026 Decidualization-empowered ECM hydrogel integrating sustained Tβ4 release drives endometrial regeneration in intrauterine adhesionsTB-500 · PMID 41565687 Nature communications Mice model and in vitro PubMed · DOI
8 2025 Plasmacytoid dendritic cells alleviate allergic asthma via airway epithelial cell-dependent thymosin β4 expressionTB-500 · PMID 39978686 The Journal of allergy and clinical immunology Mice model and in vitro PubMed · DOI
9 2025 Tβ4-Engineered ADSC Extracellular Vesicles Rescue Cell Senescence Through Separable Microneedle Patches for Diabetic Wound HealingTB-500 · PMID 40279568 Advanced science (Weinheim, Baden-Wurttemberg, Germany) Rats model PubMed · DOI

Studies by model

  • Rats · 5 studies
  • In vitro · 3 studies
  • Mice · 3 studies
  • C. elegans · 1 study

What this index does not include

Human research of any kind: publications typed by PubMed as human studies or case reports, and papers whose titles or abstracts describe human subjects, are removed by rule. Literature overviews, meta-analyses, editorials and letters are removed because they summarise rather than report. Papers whose titles contain usage or outcome language that would not pass this site's research-use-only copy rules are dropped rather than reworded, since a published title is a fact that cannot be edited.

Nothing on this page is a statement about effects in humans, a recommendation, or a description of the material supplied. Glow is supplied for laboratory research only.

How this index is built

PubMed is searched on the names the literature uses for the components of Glow (GHK-Cu, glycyl-L-histidyl-L-lysine, copper tripeptide, BPC 157, BPC-157, pentadecapeptide BPC, thymosin beta-4, thymosin beta 4, thymosin β4, Tβ4, TB-500), restricted to records indexed to an animal or cell model, in English, with an abstract. Clinical publication types, human-subject language and overview-type publications are excluded. The compound must be named in the title. Candidates are ranked by title match, indexing quality and year; the shortlist is read by a person before it is published, and a small blocklist holds records rejected on that read. The list was resolved on 2026-10-12 and is re-run deliberately, never on a timer.

Questions

Are there human studies of Glow in this index?

No, by design. This index lists animal and cell-based research only. Publications typed as human studies, case reports or literature overviews, and papers whose titles or abstracts describe human subjects, are excluded by rule before anything is listed. Eon Peptides supplies Glow for laboratory research and makes no statement about use in humans.

Which research models appear most often for Glow?

Across the 9 studies listed: Rats (5), In vitro (3), Mice (3), C. elegans (1). A model label is taken from PubMed's indexing of each paper, or from its title and abstract when the record is too new to be indexed. It describes the study, not the material.

How are the studies selected?

A PubMed search on the published names of the compound (GHK-Cu, glycyl-L-histidyl-L-lysine, copper tripeptide, BPC 157, BPC-157, pentadecapeptide BPC, thymosin beta-4, thymosin beta 4, thymosin β4, Tβ4, TB-500) is filtered to records indexed to an animal or cell model, with clinical publication types, human-subject language and overview-type publications removed. The compound must be named in the title. Remaining records are ranked by title match, indexing quality and year, and the top 9 are listed after a manual read. The list was resolved against PubMed on 2026-10-12.

Does a listing here say anything about the Glow Eon Peptides sells?

No. A listing records that a study was published and what it examined. It says nothing about the properties, quality or intended use of any material. What Eon Peptides does document about its own Glow is on the certificate pages: lot-level identity and purity results from independent laboratories.

Related pages

For research use only. Not for human or veterinary use. Preclinical and in-vitro studies only: animal models and cell-based work indexed in PubMed. Human trials, case reports and literature overviews are excluded by rule.